Company Data
Forte Biosciences Inc.
Ticker
FBRX
Current Price
$18.695 2.1%
Market Cap
$234.2M
Price Target
Refer to Report
Volume
19.7K
52wk Range
$4.9 - $28.68
Overview
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.